Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results
A.G. Badoian- D.S. Grankin
- O.V. Krestyaninov
- U.Sh. Sharafutdinov
- S.N. Manukian
- A.A. Baranov
- D.A. Khelimskii
Published 2024-11-08
Keywords
- Angioplasty, Balloon,
- Complications,
- Follow-Up Studies,
- Hypertension, Pulmonary,
- Pulmonary Artery
- Retrospective Studies ...More
How to Cite
Copyright (c) 2024 Badoian A.G., Grankin D.S., Krestyaninov O.V., Sharafutdinov U.Sh., Manukian S.N., Baranov A.A., Khelimskii D.A.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Background: Data on the short-term efficacy and safety of balloon pulmonary angioplasty (BPA) in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) are widely presented in the world literature; meanwhile information on long-term patient outcomes is very limited.
Objective: The study aimed at the assessing of the short- and long-term results of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension who completed all BPA sessions.
Methods: We conducted a retrospective data analysis on 144 patients with a diagnosis of CTEPH who have completed BPA series in the common center from August 2015 through April 2023. Clinical and procedural results including the data from right heart catheterization, as well as long-term outcomes were collected and evaluated. Nonparametric rank sum tests were used to assess changes in hemodynamic parameters of the pulmonary artery before and after BPA. Survival analysis was performed using the Kaplan-Meier method: the impact of individual and procedure-related factors on the occurrence of death in the long-term follow-up period was assessed with univariate and multivariate logistic regressions.
Results: A total of 446 BPA sessions were performed across 144 patients. The median value of mean pulmonary artery pressure (mPAP) decreased significantly by 9 mmHg (from 41 to 32). Out of 446 BPA sessions, there were 4 periprocedural deaths (0.9% of the number of procedures and 2.7% of the number of patients). Of the 134 patients available for contact, 26 (19.4%) died in the long-term period. Overall, 1- and 3- year survival probabilities were 93% and 82%, respectively. Multivariable logistic regression analysis showed that the chronic obstructive pulmonary disease (OR: 7.8 (1.86, 36.7), p = 0.006), coronary artery disease (OR: 3.78 (1.28, 11.2), p = 0.02) and a smaller decrease of mPAP after last BPA (OR: 0.91 (0.86, 0.97), p = 0.003) were independently associated with a death at follow-up period. Additional receiver operating characteristic (ROC) analysis revealed that a change in mPAP by 4.5 mmHg was the most effective predictor of death at follow-up with sensitivity and specificity equal to 0.68 and 0.60, respectively.
Conclusion: Balloon pulmonary angioplasty in patients with CTEPH is a safe procedure with significant enhancement of pulmonary hemodynamics but long-term results remain still unsatisfactory that emphasizes the complexity of this cohort of patients and the demand for developing algorithms for their treatment and monitoring.
Received 26 June 2024. Revised 26 July 2024. Accepted 1 October 2024.
Funding
The study did not have sponsorship.
Conflict of interest
The authors declare no conflict of interest.
Contribution of the authors
Conception and study design: A.G. Badoian, O.V. Krestyaninov
Data collection and analysis: A.G. Badoian, U.Sh. Sharafutdinov, S.N. Manukian
Statistical analysis: A.G. Badoian, A.A. Baranov
Drafting the article: A.G. Badoian, A.A. Baranov, D.A. Khelimskii, D.S. Grankin
Critical revision of the article: O.V. Krestyaninov, D.S. Grankin
Final approval of the version to be published: A.G. Badoian, D.S. Grankin, O.V. Krestyaninov, U.Sh. Sharafutdinov, S.N. Manukian, A.A. Baranov, D.A. Khelimskii
References
- Васильцева О.Я., Едемский А.Г., Зейналов Д.Ф., Кливер Е.Н., Усов В.Ю., Гранкин Д.С., Сирота Д.А., Чернявский А.М. Возможности успешного лечения хронической тромбоэмболической легочной гипертензии. Терапевтический архив. 2024;96(1):58-62. https://doi.org/10.26442/00403660.2024.01.202557 Vasiltseva O.Y., Edemskiy A.G., Zeinalov D.F., Kliver E.N., Ussov W.Y., Grankin D.S., Sirota D.A., Chernyavskiy A.M. Therapies of chronic thromboembolic pulmonary hypertension: a review. Terapevticheskii arkhiv. 2024;96(1):58-62. (In Russ.) https://doi.org/10.26442/00403660.2024.01.202557
- Яровой С.Ю., Данилов Н.М., Матчин Ю.Г., Чазова И.Е. Структурные изменения легочных артерий после транслюминальной баллонной ангиопластики у пациентов с хронической тромбоэмболической легочной гипертензией. Евразийский кардиологический журнал. 2020;(4):12-20. https://doi.org/10.38109/2225-1685-2020-4-12-20 Yarovoy S.Y., Danilov N.M., Matchin Yu.G., Chazova I.E. Structural changes of the pulmonary arteries after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Eurasian Heart Journal. 2020;(4):12-20. (In Russ.) https://doi.org/10.38109/2225-1685-2020-4-12-20
- Марукян Н.В., Симакова М.А., Приворотский В.В., Зверев Д.А., Моисеева О.М. Результаты этапной баллонной ангиопластики ветвей легочной артерии у пациентов с хронической тромбоэмболической легочной гипертензией. Евразийский кардиологический журнал. 2019;(2S):322. Marukyan N.V., Simakova M.A., Privorotskiy V.V., Zverev D.A., Moiseeva O.M. Results of staged balloon angioplasty of pulmonary artery branches in patients with chronic thromboembolic pulmonary hypertension. Eurasian Heart Journal. 2019;(2S):322. (In Russ.)
- Данилов Н.М., Матчин Ю.Г., Чернявский А.М., Едемский А.Г., Гранкин Д.С., Сагайдак О.В., Чазова И.Е., Бойцов С.А., Караськов А.А. Транслюминальная баллонная ангиопластика легочных артерий у больных с неоперабельной хронической тромбоэмболической легочной гипертензией. Терапевтический архив. 2019;91(4):43-47. https://doi.org/10.26442/00403660.2019.04.000100 Danilov N.M., Matchin Y.G., Chernyavsky A.M., Edemsky A.G., Grankin D.S., Sagaydak O.V., Chazova I.E., Boytsov S.A., Karaskov A.M. Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension. Terapevticheskii arkhiv. 2019;91(4):43-47. (In Russ.) https://doi.org/10.26442/00403660.2019.04.000100
- Петросян К.В., Горбачевский С.В., Жеблави И.А., Соболев А.В., Дадабаев Г.М. Транслюминальная баллонная ангиопластика ветвей легочной артерии при лечении больных с хронической тромбоэмболической легочной гипертензией и высоким хирургическим риском (четырехлетний опыт). Грудная и сердечно-сосудистая хирургия. 2020;4(62):324-344. https://doi.org/10.24022/0236-2791-2020-62-4-334-344 Petrosyan K.V., Gorbachevskiy S.V., Jeblawi I.A., Sobolev A.V., Dadabaev G.M. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with high surgical risk (four years experience). Russian Journal of Thoracic and Cardiovascular Surgery. 2020;62(4):334-344. (In Russ.). https://doi.org/10.24022/0236-2791-2020-62-4-334-344
- Kopeć G., Forfia P., Abe K., Beaudet A., Gressin V., Jevnikar M., Meijer C., Tan Y.Z., Moiseeva O., Sheares K., Skoro-Sajer N., Terra-Filho M., Whitford H., Zhai Z., Heresi G.A. Recognition, diagnosis, and operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH): A global cross-sectional scientific survey (CLARITY). Pulm Circ. 2024;14(1):e12330. PMID: 38384932; PMCID: PMC10880430. https://doi.org/10.1002/pul2.12330
- Agustí A., Celli B.R., Criner G.J., Halpin D., Anzueto A., Barnes P., Bourbeau J., Han M.K., Martinez F.J., de Oca M.M., Mortimer K., Papi A., Pavord I., Roche N., Salvi S., Sin D.D., Singh D., Stockley R., Varela M.V.L., Wedzicha J.A., Vogelmeier C.F. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Respirology. 2023;28(4):316-338. PMID: 36856440. https://doi.org/10.1111/resp.14486
- Zoghbi W.A., Adams D., Bonow R.O., Enriquez-Sarano M., Foster E., Grayburn P.A., Hahn R.T., Han Y., Hung J., Lang R.M., Little S.H., Shah D.J., Shernan S., Thavendiranathan P., Thomas J.D., Weissman N.J. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303-371. PMID: 28314623. https://doi.org/10.1016/j.echo.2017.01.007
- Voorburg J.A., Cats V.M., Buis B., Bruschke A.V. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest. 1988;94(6):1249-1253. PMID: 2973404. https://doi.org/10.1378/chest.94.6.1249
- Calé R., Ferreira F., Pereira A.R., Repolho D., Sebaiti D., Alegria S., Vitorino S., Santos P., Pereira H., Brenot P., Loureiro M.J. Safety and efficacy of balloon pulmonary angioplasty in a Portuguese pulmonary hypertension expert center. Rev Port Cardiol (Engl Ed). 2021;40(10):727-737. PMID: 34857110. https://doi.org/10.1016/j.repce.2021.05.001
- Brenot P., Jaïs X., Taniguchi Y., Garcia Alonso C., Gerardin B., Mussot S., Mercier O., Fabre D., Parent F., Jevnikar M., Montani D., Savale L., Sitbon O., Fadel E., Humbert M., Simonneau G. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(5):1802095. PMID: 31023842; PMCID: PMC6853610. https://doi.org/10.1183/13993003.02095-2018
- Olsson K.M., Wiedenroth C.B., Kamp J.C., Breithecker A., Fuge J., Krombach G.A., Haas M., Hamm C., Kramm T., Guth S., Ghofrani H.A., Hinrichs J.B., Cebotari S., Meyer K., Hoeper M.M., Mayer E., Liebetrau C., Meyer B.C. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience. Eur Respir J. 2017;49(6):1602409. PMID: 28596435. https://doi.org/10.1183/13993003.02409-2016
- van Thor M.C.J., Lely R.J., Braams N.J., Ten Klooster L., Beijk M.A.M., Heijmen R.H., van den Heuvel D.A.F., Rensing B.J.W.M., Snijder R.J., Vonk Noordegraaf A., Nossent E.J., Meijboom L.J., Symersky P., Mager J.J., Bogaard H.J., Post M.C. Safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension in the Netherlands. Neth Heart J. 2020;28(2):81-88. PMID: 31782109; PMCID: PMC6977797. https://doi.org/10.1007/s12471-019-01352-6
- Aoki T., Sugimura K., Tatebe S., Miura M., Yamamoto S., Yaoita N., Suzuki H., Sato H., Kozu K., Konno R., Miyata S., Nochioka K., Satoh K., Shimokawa H. Comprehensive evaluation of the effectiveness and safety of balloon pulmonary angioplasty for inoperable chronic thrombo-embolic pulmonary hypertension: long-term effects and procedure-related complications. Eur Heart J. 2017;38(42):3152-3159. PMID: 29029023. https://doi.org/10.1093/eurheartj/ehx530
- Inami T., Kataoka M., Yanagisawa R., Ishiguro H., Shimura N., Fukuda K., Yoshino H., Satoh T. Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Circulation. 2016;134(24):2030-2032. PMID: 27956405. https://doi.org/10.1161/CIRCULATIONAHA.116.024201
- Strange G., Gabbay E., Kermeen F., Williams T., Carrington M., Stewart S., Keogh A. Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: the delay study. Pulm Circ. 2013;3(1):89-94. PMID: 23662179; PMCID: PMC3641745. https://doi.org/10.4103/2045-8932.109919
- Simonneau G., Torbicki A., Dorfmüller P., Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160112. PMID: 28356405; PMCID: PMC9488693. https://doi.org/10.1183/16000617.0112-2016
- Shinkura Y., Nakayama K., Yanaka K., Kinutani H., Tamada N., Tsuboi Y., Satomi-Kobayashi S., Otake H., Shinke T., Emoto N., Hirata K.I. Extensive revascularisation by balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension beyond haemodynamic normalisation. EuroIntervention. 2018;13(17):2060-2068. PMID: 28804055. https://doi.org/10.4244/EIJ-D-17-00157
- Humbert M., Kovacs G., Hoeper M.M., Badagliacca R., Berger R.M.F., Brida M., Carlsen J., Coats A.J.S., Escribano-Subias P., Ferrari P., Ferreira D.S., Ghofrani H.A., Giannakoulas G., Kiely D.G., Mayer E., Meszaros G., Nagavci B., Olsson K.M., Pepke-Zaba J., Quint J.K., Rådegran G., Simonneau G., Sitbon O., Tonia T., Toshner M., Vachiery J.L., Vonk Noordegraaf A., Delcroix M., Rosenkranz S.; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-3731. Erratum in: Eur Heart J. 2023;44(15):1312. PMID: 36017548. https://doi.org/10.1093/eurheartj/ehac237
- Lang I.M. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: clinical outcomes. Eur Cardiol. 2023;18:e11. PMID: 37405334; PMCID: PMC10316354. https://doi.org/10.15420/ecr.2022.29